1. Medicines Management and Therapeutics Committee . Elective surgery and invasive procedures in patients taking warfarin or a direct. Oral Anticoagulant 2020; 10: 1.
Google Scholar2. Pastori, D, Menichelli, D, Cammisotto, V, et al. Use of direct oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and comparison of the international guidelines. Front Cardiovasc Med 2021; 8: 715878.
Google Scholar | Crossref | Medline3. Kim, JW, Kim, TW, Ryu, KH, et al. Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery. J Int Med Res 2020; 48: 300060519896889.
Google Scholar | SAGE Journals | ISI4. Comarmond, C, Jego, P, Veyssier-Belot, C, et al. Cessation of oral anticoagulants in antiphospholipid syndrome. Lupus 2017; 26: 1291–1296.
Google Scholar | SAGE Journals | ISI5. Pengo, V, Ruffatti, A, Legnani, C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010; 8: 237–242.
Google Scholar | Crossref | Medline | ISI6. Pengo, V, Hoxha, A, Andreoli, L, et al. Trial of rivaroxaban in antiPhospholipid syndrome (TRAPS): two‐year outcomes after the study closure. J Thromb Haemost 2021; 19: 531–535.
Google Scholar | Crossref | Medline7. Pengo, V, Ruffatti, A, Legnani, C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 2011; 118: 4714–4718.
Google Scholar | Crossref | Medline | ISI8. Schulman, S, Svenungsson, E, Granqvist, S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998; 104: 332–338.
Google Scholar | Crossref | Medline | ISI9. Kearon, C, Gent, M, Hirsh, J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New Engl J Med 1999; 340: 901–907.
Google Scholar | Crossref | Medline | ISI10. Hogan, WJ, McBane, RD, Santrach, PJ, et al. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clinic Proc 2000; 75: 971–976.
Google Scholar | Crossref | Medline | ISI11. Atisha-Fregoso, Y, Espejo-Poox, E, Carrillo-Maravilla, E, et al. Perioperative management of patients with antiphospholipid syndrome: a single-center experience. Rheumatol Int 2017; 37: 1159–1164.
Google Scholar | Crossref | Medline12. Raso, S, Sciascia, S, Kuzenko, A, et al. Bridging therapy in antiphospholipid syndrome and antiphospholipid antibodies carriers: case series and review of the literature. Autoimmun Rev 2015; 14: 36–42.
Google Scholar | Crossref | Medline13. Erkan, D, Leibowitz, E, Berman, J, et al. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002; 29: 843–9.
Google Scholar | Medline | ISI14. Nutescu, EA, Burnett, A, Fanikos, J, et al. Pharmacology of anticoagulants used in the treatment of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 15–31.
Google Scholar | Crossref | Medline15. Roth, J, Margalit, NS, Kesler, A, et al. Peri-operative brainstem infarct in a patient with antiphospholipid antibody (APLA) syndrome. Acta Neurochirurgica 2006; 148: 1111–1115, discussion 1115.
Google Scholar | Crossref | Medline16. Cole, SM, Patterson, MB, Cupp, CL. Tonsillectomy in the anticoagulated patient. Ann Otol Rhinol Laryngol 2007; 116: 589–593.
Google Scholar | SAGE Journals | ISI17. Roman, PEF, DeVore, AD, Welsby, IJ. Techniques and applications of perioperative therapeutic plasma exchange. Curr Opin Anaesthesiol 2014; 27: 57–64.
Google Scholar | Crossref | Medline18. Arias, EJ, Bruck, B, Vellimana, AK, et al. Plasmapheresis for management of antiphospholipid syndrome in the neurosurgical patient. Oper Neurosurg 2019; 16: E124–E129.
Google Scholar | Crossref | Medline19. Petri, M . Thrombosis and systemic lupus erythematosus: the hopkins lupus cohort perspective. Scand J Rheumatol 1996; 25: 191–193.
Google Scholar | Crossref | Medline | ISI20. Belmont, HM, Buyon, J, Giorno, R, et al. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 376–383.
Google Scholar | Crossref | Medline21. Belmont, HM, Abramson, SB, Lie, JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39: 9–22.
Google Scholar | Crossref | Medline22. Luo, S, Hu, D, Wang, M, et al. Complement in hemolysis- and thrombosis- related diseases. Front Immunol 2020; 11: 1212.
Google Scholar | Crossref | Medline23. Belmont, HM, Nwaukoni, J, Buyon, JP. Complement activation as a marker for increased thrombosis risk in SLE patients with antiphospholipid antibodies. Arthritis Rheumatol 2015; 67(suppl 10): 736.
Google Scholar